MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20244674

August 20, 2024

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.1% (5ml:5mg)

化学药品

August 20, 2024

Company Information

Applicant Company

安徽省合肥市肥西县桃花镇玉兰大道41号

Manufacturing Company

安徽省合肥市肥西县桃花镇玉兰大道41号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath